https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Fat1 cadherin provides a novel minimal residual disease marker in acute lymphoblastic leukemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:18969 Sat 24 Mar 2018 07:58:53 AEDT ]]> Persistent MRD before and after allogeneic BMT predicts relapse in children with acute lymphoblastic leukaemia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:27000 50. A Cox multivariate regression model for LFS retained both B-other ALL subtype (hazard ratio 4·1, P = 0·0062) and MRD persistence post-HSCT (hazard ratio 3·9, P = 0·0070) as independent adverse prognostic variables. Persistent MRD could be used to direct post-HSCT therapy.]]> Sat 24 Mar 2018 07:25:49 AEDT ]]>